Avista Therapeutics Expands AI Gene Therapy Platform to Break Barriers in the Delivery of Genetic Medicines

PITTSBURGH, Jan. 9, 2026 /PRNewswire/ -- Avista Therapeutics, a preclinical gene therapy company built on deep clinical, computational and gene therapy expertise, today announced the significant expansion of its gene therapy platform. Through an AI-driven expansion of its capsid design...

Read More